发明名称 SUBCUTANEOUS OUTPATIENT MANAGEMENT
摘要 A method of administering insulin includes receiving subcutaneous information for a patient at a computing device and executing a subcutaneous outpatient program for determining recommended insulin dosages. The subcutaneous outpatient program includes obtaining blood glucose data of the patient from a glucometer in communication with the computing device, aggregating blood glucose measurements to determine a representative aggregate blood glucose measurement associated with at least one scheduled blood glucose time interval, and determining a next recommended insulin dosage for the patient based on the representative aggregate blood glucose measurement and the subcutaneous information. The method also includes transmitting the next recommended insulin dosage to a portable device associated with the patient. The portable device displays the next recommended insulin dosage.
申请公布号 US2016117481(A1) 申请公布日期 2016.04.28
申请号 US201514922763 申请日期 2015.10.26
申请人 Aseko, Inc. 发明人 Booth Robert C;Hebblewhite Harry
分类号 G06F19/00;A61M5/172;A61M5/178;A61M31/00 主分类号 G06F19/00
代理机构 代理人
主权项 1. A method comprising: receiving, at data processing hardware, subcutaneous information for a patient; executing, at the data processing hardware, a subcutaneous outpatient program for determining recommended insulin dosages, the subcutaneous outpatient program comprising: obtaining, at the data processing hardware, blood glucose data of the patient from a glucometer in communication with the computing device, the blood glucose data including blood glucose measurements of the patient, blood glucose times associated with the blood glucose measurements, and insulin dosages administered by the patient and associated with the blood glucose measurements;determining, by the data processing hardware, scheduled blood glucose time intervals associated with the blood glucose measurements based on the blood glucose times;aggregating, by the data processing hardware, the blood glucose measurements associated with at least one of the scheduled blood glucose time intervals to determine a representative aggregate blood glucose measurement associated with the at least one scheduled blood glucose time interval;determining, by the data processing hardware, a next recommended insulin dosage for the patient based on the representative aggregate blood glucose measurement and the subcutaneous information; andtransmitting the next recommended insulin dosage from the data processing hardware to a portable device associated with the patient, the portable device displaying the next recommended insulin dosage.
地址 Greenville SC US